Novel active fixation lead guided by electrical delay can improve response to cardiac resynchronization therapy in heart failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel active fixation lead guided by electrical delay can improve response to cardiac resynchronization therapy in heart failure

Published:2021-12-24 Issue:1 Volume:9 Page:146-154
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Casale Matteo¹^ORCID,Mezzetti Maurizio¹,Gigliotti De Fazio Marianna²,Caccamo Loredana¹,Busacca Paolo¹,Dattilo Giuseppe³^ORCID

Affiliation:

1. ASUR Marche ‐ Area Vasta 1, Operative Unit of ICCU and Cardiology Hospital S. Maria della Misericordia Urbino Italy

2. Department of Clinical and Experimental Medicine, Operative Unit of Internal Medicine University of Messina Messina Italy

3. Department of Clinical and Experimental Medicine, Operative Unit of Cardiology University of Messina Messina Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13727

Reference23 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

3. Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

4. Effects of cardiac resynchronization therapy on long-term quality of life: An analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study

5. Opportunity to Increase Life Span in Narrow QRS Cardiac Resynchronization Therapy Recipients by Deactivating Ventricular Pacing

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vericiguat in heart failure with reduced ejection fraction: hope or solid reality?;Heart Failure Reviews;2024-07-23

2. Ventricular tachycardia and non-Hodgkin's lymphoma. Syncope in a 33-year-old young;Cor et Vasa;2023-10-15

3. The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population;Journal of Clinical Medicine;2023-09-28

4. Atrial fibrillation and QT corrected. What is the best formula to use?;European Journal of Clinical Investigation;2023-05-12

5. Anomalous origin of the left circumflex artery from right sinus of Valsalva: a rare case but with great clinical relevance;Cor et Vasa;2023-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3